A leading global pharmaceutical solutions organization, Cencora specializes in drug distribution and healthcare services, connecting manufacturers with providers. The company plays a critical role in the pharmaceutical supply chain, making it a key player for investors monitoring healthcare logistics and wholesale trends.
3 members of Congress have disclosed 7 trades in Cencora, Inc. (COR), a Healthcare company. The buy/sell breakdown shows 2 purchases versus 5 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2015-12-17 | MICHAEL T. MCCAUL | sell | $1K – $15K |
| 2015-10-06 | MICHAEL T. MCCAUL | sell | $50K – $100K |
| 2015-09-02 | MICHAEL T. MCCAUL | buy | $1K – $15K |
| 2015-05-27 | Thomas MacArthur | sell | $15K – $50K |
| 2015-05-04 | MICHAEL T. MCCAUL | sell | $50K – $100K |
| 2015-05-04 | MICHAEL T. MCCAUL | sell | $1K – $15K |
| 2011-04-11 | David P. Roe | buy | $46 |